Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 16, 2016
GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo
Parmanand Singh, Silvia González-Ramos, Marina Mojena, et al.
European Heart Journal. Cardiovascular Imaging
|
December 7, 2018
Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial
Borek Foldyna, James E Udelson, Júlia Karády, et al.
JAMA Cardiology
|
December 22, 2021
Differences in Cardiovascular Risk, Coronary Artery Disease, and Cardiac Events Between Black and White Individuals Enrolled in the PROMISE Trial
Lili Zhang, Devvora Olalere, Thomas Mayrhofer, et al.
JACC. Cardiovascular Imaging
|
August 4, 2022
Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial Results
Maros Ferencik, Thomas Mayrhofer, Michael T Lu, et al.
European Radiology
|
January 27, 2021
Small whole heart volume predicts cardiovascular events in patients with stable chest pain: insights from the PROMISE trial
Borek Foldyna, Roman Zeleznik, Parastou Eslami, et al.
Diabetes Care
|
February 9, 2021
Association of Metabolic Phenotypes With Coronary Artery Disease and Cardiovascular Events in Patients With Stable Chest Pain
Andreas A Kammerlander, Thomas Mayrhofer, Maros Ferencik, et al.
Atherosclerosis
|
April 28, 2015
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial
Hamed Emami, Esad Vucic, Sharath Subramanian, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 18, 2015
HIF-1α and PFKFB3 Mediate a Tight Relationship Between Proinflammatory Activation and Anerobic Metabolism in Atherosclerotic Macrophages
Ahmed Tawakol, Parmanand Singh, Marina Mojena, et al.
JAMA Cardiology
|
January 12, 2018
Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial
Maros Ferencik, Thomas Mayrhofer, Daniel O Bittner, et al.
Radiology
|
November 28, 2017
Central Core Laboratory versus Site Interpretation of Coronary CT Angiography: Agreement and Association with Cardiovascular Events in the PROMISE Trial
Michael T Lu, Nandini M Meyersohn, Thomas Mayrhofer, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 16, 2016
GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo
Parmanand Singh, Silvia González-Ramos, Marina Mojena, et al.
European Heart Journal. Cardiovascular Imaging
|
December 7, 2018
Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial
Borek Foldyna, James E Udelson, Júlia Karády, et al.
JAMA Cardiology
|
December 22, 2021
Differences in Cardiovascular Risk, Coronary Artery Disease, and Cardiac Events Between Black and White Individuals Enrolled in the PROMISE Trial
Lili Zhang, Devvora Olalere, Thomas Mayrhofer, et al.
JACC. Cardiovascular Imaging
|
August 4, 2022
Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial Results
Maros Ferencik, Thomas Mayrhofer, Michael T Lu, et al.
European Radiology
|
January 27, 2021
Small whole heart volume predicts cardiovascular events in patients with stable chest pain: insights from the PROMISE trial
Borek Foldyna, Roman Zeleznik, Parastou Eslami, et al.
Diabetes Care
|
February 9, 2021
Association of Metabolic Phenotypes With Coronary Artery Disease and Cardiovascular Events in Patients With Stable Chest Pain
Andreas A Kammerlander, Thomas Mayrhofer, Maros Ferencik, et al.
Atherosclerosis
|
April 28, 2015
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial
Hamed Emami, Esad Vucic, Sharath Subramanian, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 18, 2015
HIF-1α and PFKFB3 Mediate a Tight Relationship Between Proinflammatory Activation and Anerobic Metabolism in Atherosclerotic Macrophages
Ahmed Tawakol, Parmanand Singh, Marina Mojena, et al.
JAMA Cardiology
|
January 12, 2018
Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial
Maros Ferencik, Thomas Mayrhofer, Daniel O Bittner, et al.
Radiology
|
November 28, 2017
Central Core Laboratory versus Site Interpretation of Coronary CT Angiography: Agreement and Association with Cardiovascular Events in the PROMISE Trial
Michael T Lu, Nandini M Meyersohn, Thomas Mayrhofer, et al.
Page
of 6